Central Bank & Trust CO Vertex Pharmaceuticals Inc Transaction History

Central Bank & Trust CO

$708 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$407.69 - $446.08 $23,646 - $25,872	-58 Reduced 59.18%	40 $16,000
Q4 2023 Jan 09, 2024	SELL	$343.0 - $410.68 $5,488 - $6,570	-16 Reduced 14.04%	98 $39,000
Q2 2023 Jul 13, 2023	SELL	$314.42 - $351.91 $8,489 - $9,501	-27 Reduced 19.15%	114 $40,000
Q1 2023 Apr 13, 2023	BUY	$283.23 - $323.1 $30,872 - $35,217	109 Added 340.63%	141 $44,000
Q3 2022 Oct 20, 2022	SELL	$273.83 - $305.53 $36,419 - $40,635	-133 Reduced 80.61%	32 $9,000
Q2 2022 Jul 22, 2022	SELL	$234.96 - $292.55 $18,796 - $23,404	-80 Reduced 32.65%	165 $46,000
Q1 2022 Apr 18, 2022	BUY	$221.42 - $260.97 $36,534 - $43,060	165 Added 206.25%	245 $64,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $220,200 - $277,971	-1,244 Reduced 93.96%	80 $18,000
Q3 2021 Oct 19, 2021	BUY	$181.39 - $202.99 $4,534 - $5,074	25 Added 1.92%	1,324 $240,000
Q2 2021 Jul 16, 2021	BUY	$187.49 - $221.1 $10,499 - $12,381	56 Added 4.51%	1,299 $262,000
Q1 2021 Apr 20, 2021	BUY	$207.02 - $241.31 $14,491 - $16,891	70 Added 5.97%	1,243 $267,000
Q4 2020 Jan 12, 2021	BUY	$207.01 - $276.09 $145,321 - $193,815	702 Added 149.04%	1,173 $277,000
Q3 2020 Oct 08, 2020	BUY	$255.65 - $303.1 $107,373 - $127,302	420 Added 823.53%	471 $128,000
Q2 2020 Jul 15, 2020	BUY	$225.48 - $295.8 $11,499 - $15,085	51 New	51 $15,000
Q1 2020 Apr 14, 2020	SELL	$199.77 - $247.81 $10,188 - $12,638	-51 Closed	0 $0
Q1 2020 Apr 14, 2020	BUY	$199.77 - $247.81 $10,188 - $12,638	51 New	51 $12,000
Q2 2019 Jul 16, 2019	SELL	$164.61 - $190.37 $3,950 - $4,568	-24 Closed	0 $0
Q3 2018 Nov 23, 2018	BUY	$167.73 - $192.74 $4,025 - $4,625	24 New	24 $5,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Account